118 related articles for article (PubMed ID: 20043680)
1. Urotensin-II receptor modulators as potential drugs.
Maryanoff BE; Kinney WA
J Med Chem; 2010 Apr; 53(7):2695-708. PubMed ID: 20043680
[No Abstract] [Full Text] [Related]
2. Identification of new agonists of urotensin-II from a cyclic peptide library.
Odagami T; Tsuda Y; Kogami Y; Kouji H; Okada Y
Bioorg Med Chem; 2009 Sep; 17(18):6742-7. PubMed ID: 19695883
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
[TBL] [Abstract][Full Text] [Related]
4. Nonpeptide Urotensin-II receptor agonists and antagonists: review and structure-activity relationships.
Lescot E; Bureau R; Rault S
Peptides; 2008 May; 29(5):680-90. PubMed ID: 18022732
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor.
Batuwangala M; Camarda V; McDonald J; Marzola E; Lambert DG; Ng LL; Calo' G; Regoli D; Trapella C; Guerrini R; Salvadori S
Peptides; 2009 Jun; 30(6):1130-6. PubMed ID: 19463746
[TBL] [Abstract][Full Text] [Related]
6. Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor.
Carotenuto A; Auriemma L; Merlino F; Yousif AM; Marasco D; Limatola A; Campiglia P; Gomez-Monterrey I; Santicioli P; Meini S; Maggi CA; Novellino E; Grieco P
J Med Chem; 2014 Jul; 57(14):5965-74. PubMed ID: 24992374
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of potent cystine-free cyclic hexapeptide agonists at the human urotensin receptor.
Foister S; Taylor LL; Feng JJ; Chen WL; Lin A; Cheng FC; Smith AB; Hirschmann R
Org Lett; 2006 Apr; 8(9):1799-802. PubMed ID: 16623554
[TBL] [Abstract][Full Text] [Related]
8. Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites.
Holleran BJ; Beaulieu ME; Proulx CD; Lavigne P; Escher E; Leduc R
Biochem J; 2007 Feb; 402(1):51-61. PubMed ID: 17064254
[TBL] [Abstract][Full Text] [Related]
9. [Urotensin II and cardiac disease].
Nishikimi T
Nihon Rinsho; 2004 Sep; 62 Suppl 9():722-6. PubMed ID: 15506482
[No Abstract] [Full Text] [Related]
10. Urotensin-II receptor peptide agonists.
Carotenuto A; Grieco P; Novellino E; Rovero P
Med Res Rev; 2004 Sep; 24(5):577-88. PubMed ID: 15224381
[TBL] [Abstract][Full Text] [Related]
11. Urotensin-II receptor ligands. From agonist to antagonist activity.
Grieco P; Carotenuto A; Campiglia P; Marinelli L; Lama T; Patacchini R; Santicioli P; Maggi CA; Rovero P; Novellino E
J Med Chem; 2005 Nov; 48(23):7290-7. PubMed ID: 16279788
[TBL] [Abstract][Full Text] [Related]
12. Biological properties and functional determinants of the urotensin II receptor.
Proulx CD; Holleran BJ; Lavigne P; Escher E; Guillemette G; Leduc R
Peptides; 2008 May; 29(5):691-9. PubMed ID: 18155322
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle.
Behm DJ; Ao Z; Camarda V; Aiyar NV; Johns DG; Douglas SA
Eur J Pharmacol; 2005 Jun; 516(3):276-81. PubMed ID: 15975570
[TBL] [Abstract][Full Text] [Related]
14. [Discovery and clinical implications of urotensin II].
Naruse M; Nagata D; Tanabe A; Imaki T
Nihon Rinsho; 2004 Sep; 62 Suppl 9():685-93. PubMed ID: 15506473
[No Abstract] [Full Text] [Related]
15. Another ligand fishing for G protein-coupled receptor 14. Discovery of urotensin II-related peptide in the rat brain.
Sugo T; Mori M
Peptides; 2008 May; 29(5):809-12. PubMed ID: 17628210
[TBL] [Abstract][Full Text] [Related]
16. Urantide conformation and interaction with the urotensin-II receptor.
Brancaccio D; Limatola A; Campiglia P; Gomez-Monterrey I; Novellino E; Grieco P; Carotenuto A
Arch Pharm (Weinheim); 2014 Mar; 347(3):185-92. PubMed ID: 24357333
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11).
Marzola E; Camarda V; Batuwangala M; Lambert DG; Calo' G; Guerrini R; Trapella C; Regoli D; Tomatis R; Salvadori S
Peptides; 2008 May; 29(5):674-9. PubMed ID: 17822806
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the active conformation of urotensin II.
Carotenuto A; Grieco P; Campiglia P; Novellino E; Rovero P
J Med Chem; 2004 Mar; 47(7):1652-61. PubMed ID: 15027856
[TBL] [Abstract][Full Text] [Related]
19. [A vasoactive peptide: urotensin II].
Liu GQ; Zeng ZP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):525-8. PubMed ID: 16178453
[TBL] [Abstract][Full Text] [Related]
20. Increased circulating urotensin II in cirrhosis: potential implications in liver disease.
Kemp W; Roberts S; Krum H
Peptides; 2008 May; 29(5):868-72. PubMed ID: 17913301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
